BTG Specialty Pharmaceuticals Revenue and Competitors

Location

Total Funding

Industry

Estimated Revenue & Valuation

BTG Specialty Pharmaceuticals's estimated annual revenue is currently $28.9M per year.(i)
BTG Specialty Pharmaceuticals's estimated revenue per employee is $201,000

Name	Title	Email/Phone

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Imaging Endpoin...	$46.2M	230	5%	N/A	N/A
#2 Southern Script...	$43.8M	218	21%	N/A	N/A
#3 Alfasigma USA	$57.1M	284	26%	N/A	N/A
#4 US WorldMeds	$24.5M	122	3%	N/A	N/A
#5 KCAS Bioanalyti...	$52.9M	263	13%	N/A	N/A
#6 BioTek reMEDys	$24.7M	123	13%	N/A	N/A
#7 Endocyte	$1.8M	18	0%	$114.3M	N/A
#8 Envision Commun...	$7.2M	36	-20%	N/A	N/A
#9 Peachtree Biore...	$13.7M	68	-7%	N/A	N/A
#10 Clearside BioMe...	$7.6M	39	-13%	$123.9M	N/A

keywords:N/A

N/A

Total Funding

144

Number of Employees

$28.9M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Thomas Kolaras has been named chief commercial officer, U.S., for SERB and BTG Specialty Pharmaceuticals, the companies said Monday.

Philadelphia, April 11, 2022 (GLOBE NEWSWIRE) -- SERB and BTG Specialty Pharmaceuticals are pleased to announce that Thomas Kolaras has been...

Together, SERB and BTG Specialty Pharmaceuticals are a growing specialty pharmaceutical group and a dedicated ally to healthcare providers...

Company Name	Revenue	Number of Employees	Employee Growth	Total Funding
#1 Sikraft Infotec...	$19.4M	144	-3%	N/A
#2 DEVANSHI ELECTR...	$28M	144	16%	N/A
#3 Bedford Stuyves...	$15M	144	7%	N/A
#4 TOTAL TRANSPORT...	$47.2M	144	31%	$132M
#5 Canadian Digita...	$15M	144	1%	N/A